Main Menu


Publications Highlights View all by category

Types of Publications

Journal Articles

Mateo, J. Porta, N. Bianchini, D. McGovern, U. Elliott, T. Jones, R. Syndikus, I. Ralph, C. Jain, S. Varughese, M. Parikh, O. Crabb, S. Robinson, A. McLaren, D. Birtle, A. Tanguay, J. Miranda, S. Figueiredo, I. Seed, G. Bertan, C. Flohr, P. Ebbs, B. Rescigno, P. Fowler, G. Ferreira, A. Riisnaes, R. Pereira, R. Curcean, A. Chandler, R. Clarke, M. Gurel, B. Crespo, M. Nava Rodrigues, D. Sandhu, S. Espinasse, A. Chatfield, P. Tunariu, N. Yuan, W. Hall, E. Carreira, S. de Bono, J.S. (2020). Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial. The lancet. oncology, Vol.21 (1), pp. 162-174.  show abstract

de Mol van Otterloo, S.R. Christodouleas, J.P. Blezer, E.L. Akhiat, H. Brown, K. Choudhury, A. Eggert, D. Erickson, B.A. Faivre-Finn, C. Fuller, C.D. Goldwein, J. Hafeez, S. Hall, E. Harrington, K.J. van der Heide, U.A. Huddart, R.A. Intven, M.P. Kirby, A.M. Lalondrelle, S. McCann, C. Minsky, B.D. Mook, S. Nowee, M.E. Oelfke, U. Orrling, K. Sahgal, A. Sarmiento, J.G. Schultz, C.J. Tersteeg, R.J. Tijssen, R.H. Tree, A.C. van Triest, B. Hall, W.A. Verkooijen, H.M. (2020). The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive Therapy. Frontiers in oncology, Vol.10, pp. 1328-?.  show abstract

Huddart, R.A. Hall, E. Lewis, R. Porta, N. Crundwell, M. Jenkins, P.J. Rawlings, C. Tremlett, J. Campani, L. Hendron, C. Hussain, S.A. James, N.D. BC2001 Investigators, (2020). Patient-reported Quality of Life Outcomes in Patients Treated for Muscle-invasive Bladder Cancer with Radiotherapy ± Chemotherapy in the BC2001 Phase III Randomised Controlled Trial. European urology, Vol.77 (2), pp. 260-268.  show abstract

Birtle, A. Johnson, M. Chester, J. Jones, R. Dolling, D. Bryan, R.T. Harris, C. Winterbottom, A. Blacker, A. Catto, J.W. Chakraborti, P. Donovan, J.L. Elliott, P.A. French, A. Jagdev, S. Jenkins, B. Keeley, F.X. Kockelbergh, R. Powles, T. Wagstaff, J. Wilson, C. Todd, R. Lewis, R. Hall, E. (2020). Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial. The lancet, Vol.395 (10232), pp. 1268-1277.

Mostafid, A.H. Porta, N. Cresswell, J. Griffiths, T.R. Kelly, J.D. Penegar, S.R. Davenport, K. McGrath, J.S. Campain, N. Cooke, P. Masood, S. Knowles, M.A. Feber, A. Knight, A. Catto, J.W. Lewis, R. Hall, E. (2020). CALIBER: a phase II randomized feasibility trial of chemoablation with mitomycin-C vs surgical management in low-risk non-muscle-invasive bladder cancer. Bju international, Vol.125 (6), pp. 817-826.  show abstract

Dearnaley, D. Griffin, C.L. Lewis, R. Mayles, P. Mayles, H. Naismith, O.F. Harris, V. Scrase, C.D. Staffurth, J. Syndikus, I. Zarkar, A. Ford, D.R. Rimmer, Y.L. Horan, G. Khoo, V. Frew, J. Venkitaraman, R. Hall, E. (2019). Toxicity and Patient-Reported Outcomes of a Phase 2 Randomized Trial of Prostate and Pelvic Lymph Node Versus Prostate only Radiotherapy in Advanced Localised Prostate Cancer (PIVOTAL). International journal of radiation oncology, biology, physics, Vol.103 (3), pp. 605-617.  show abstract

Walker, A.K. Karaszi, K. Valentine, H. Strauss, V.Y. Choudhury, A. McGill, S. Wen, K. Brown, M.D. Ramani, V. Bhattarai, S. Teo, M.T. Yang, L. Myers, K.A. Deshmukh, N. Denley, H. Browning, L. Love, S.B. Iyer, G. Clarke, N.W. Hall, E. Huddart, R. James, N.D. Hoskin, P.J. West, C.M. Kiltie, A.E. (2019). MRE11 as a Predictive Biomarker of Outcome After Radiation Therapy in Bladder Cancer. International journal of radiation oncology, biology, physics, Vol.104 (4), pp. 809-818.  show abstract

Brand, D.H. Tree, A.C. Ostler, P. van der Voet, H. Loblaw, A. Chu, W. Ford, D. Tolan, S. Jain, S. Martin, A. Staffurth, J. Camilleri, P. Kancherla, K. Frew, J. Chan, A. Dayes, I.S. Henderson, D. Brown, S. Cruickshank, C. Burnett, S. Duffton, A. Griffin, C. Hinder, V. Morrison, K. Naismith, O. Hall, E. van As, N. PACE Trial Investigators, (2019). Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial. The lancet. oncology, Vol.20 (11), pp. 1531-1543.  show abstract

Wilkins, A. Stuttle, C. Hassan, S. Blanchard, C. Cruickshank, C. Griffin, C. Probert, J. Corbishley, C.M. Parker, C. Dearnaley, D. Hall, E. (2018). Methodology for tissue sample collection within a translational sub-study of the CHHiP trial (CRUK/06/016), a large randomised phase III trial in localised prostate cancer. Clinical and translational radiation oncology, Vol.10, pp. 1-6.  show abstract

Wilson, J.M. Dearnaley, D.P. Syndikus, I. Khoo, V. Birtle, A. Bloomfield, D. Choudhury, A. Graham, J. Ferguson, C. Malik, Z. Money-Kyrle, J. O'Sullivan, J.M. Panades, M. Parker, C. Rimmer, Y. Scrase, C. Staffurth, J. Stockdale, A. Cruickshank, C. Griffin, C. Hall, E. CHHiP Investigators, (2018). The Efficacy and Safety of Conventional and Hypofractionated High-Dose Radiation Therapy for Prostate Cancer in an Elderly Population: A Subgroup Analysis of the CHHiP Trial. International journal of radiation oncology, biology, physics, Vol.100 (5), pp. 1179-1189.  show abstract

Hague, C. Foran, B. Hall, E. Guild, S. Joseph, O. Moule, R. Nutting, C. Parsons, S. Prestwich, R. Slevin, N. West, C. Thomson, D. (2018). Patient Involvement in the Design of a Phase III Trial Comparing Intensity-modulated Proton Therapy and Intensity-modulated Radiotherapy for Oropharyngeal Cancer. Clinical oncology (royal college of radiologists (great britain)), Vol.30 (5), pp. 274-276.

Wilkins, A.C. Gusterson, B. Szijgyarto, Z. Haviland, J. Griffin, C. Stuttle, C. Daley, F. Corbishley, C.M. Dearnaley, D.P. Hall, E. Somaiah, N. CHHiP Trial Investigators, (2018). Ki67 Is an Independent Predictor of Recurrence in the Largest Randomized Trial of 3 Radiation Fractionation Schedules in Localized Prostate Cancer. International journal of radiation oncology, biology, physics, Vol.101 (2), pp. 309-315.  show abstract

Nutting, C.M. Morden, J.P. Beasley, M. Bhide, S. Cook, A. De Winton, E. Emson, M. Evans, M. Fresco, L. Gollins, S. Gujral, D. Harrington, K. Joseph, M. Lemon, C. Luxon, L. van den Blink, Q. Mendes, R. Miah, A. Newbold, K. Prestwich, R. Robinson, M. Sanghera, P. Simpson, J. Sivaramalingam, M. Srihari, N.N. Sydenham, M. Wells, E. Witts, S. Hall, E. COSTAR Investigators, (2018). Results of a multicentre randomised controlled trial of cochlear-sparing intensity-modulated radiotherapy versus conventional radiotherapy in patients with parotid cancer (COSTAR; CRUK/08/004). European journal of cancer (oxford, england : 1990), Vol.103, pp. 249-258.  show abstract

Choudhury, A. West, C.M. Porta, N. Hall, E. Denley, H. Hendron, C. Lewis, R. Hussain, S.A. Huddart, R. James, N. (2017). The predictive and prognostic value of tumour necrosis in muscle invasive bladder cancer patients receiving radiotherapy with or without chemotherapy in the BC2001 trial (CRUK/01/004). British journal of cancer, Vol.116 (5), pp. 649-657.  show abstract

Dearnaley, D. Syndikus, I. Mossop, H. Khoo, V. Birtle, A. Bloomfield, D. Graham, J. Kirkbride, P. Logue, J. Malik, Z. Money-Kyrle, J. O'Sullivan, J.M. Panades, M. Parker, C. Patterson, H. Scrase, C. Staffurth, J. Stockdale, A. Tremlett, J. Bidmead, M. Mayles, H. Naismith, O. South, C. Gao, A. Cruickshank, C. Hassan, S. Pugh, J. Griffin, C. Hall, E. CHHiP Investigators, (2016). Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial. The lancet. oncology, Vol.17 (8), pp. 1047-1060.  show abstract

Harris, V.A. Staffurth, J. Naismith, O. Esmail, A. Gulliford, S. Khoo, V. Lewis, R. Littler, J. McNair, H. Sadoyze, A. Scrase, C. Sohaib, A. Syndikus, I. Zarkar, A. Hall, E. Dearnaley, D. (2015). Consensus Guidelines and Contouring Atlas for Pelvic Node Delineation in Prostate and Pelvic Node Intensity Modulated Radiation Therapy. International journal of radiation oncology*biology*physics, Vol.92 (4), pp. 874-883.

Wilkins, A. Mossop, H. Syndikus, I. Khoo, V. Bloomfield, D. Parker, C. Logue, J. Scrase, C. Patterson, H. Birtle, A. Staffurth, J. Malik, Z. Panades, M. Eswar, C. Graham, J. Russell, M. Kirkbride, P. O'Sullivan, J.M. Gao, A. Cruickshank, C. Griffin, C. Dearnaley, D. Hall, E. (2015). Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial. The lancet. oncology, Vol.16 (16), pp. 1605-1616.  show abstract

James, N.D. Hussain, S.A. Hall, E. Jenkins, P. Tremlett, J. Rawlings, C. Crundwell, M. Sizer, B. Sreenivasan, T. Hendron, C. Lewis, R. Waters, R. Huddart, R.A. BC2001 Investigators, (2012). Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer. N engl j med, Vol.366 (16), pp. 1477-1488.  show abstract

Sharma, R.A. Plummer, R. Stock, J.K. Greenhalgh, T.A. Ataman, O. Kelly, S. Clay, R. Adams, R.A. Baird, R.D. Billingham, L. Brown, S.R. Buckland, S. Bulbeck, H. Chalmers, A.J. Clack, G. Cranston, A.N. Damstrup, L. Ferraldeschi, R. Forster, M.D. Golec, J. Hagan, R.M. Hall, E. Hanauske, A.-. Harrington, K.J. Haswell, T. Hawkins, M.A. Illidge, T. Jones, H. Kennedy, A.S. McDonald, F. Melcher, T. O'Connor, J.P. Pollard, J.R. Saunders, M.P. Sebag-Montefiore, D. Smitt, M. Staffurth, J. Stratford, I.J. Wedge, S.R. NCRI CTRad Academia-Pharma Joint Working Group, Clinical development of new drug-radiotherapy combinations. Nat rev clin oncol, Vol.13 (10), pp. 627-642.  show abstract

Hall, E. Hague, C. Foran, B. Guild, S. Joseph, O. Moule, R. Nutting, C. Parsons, S. Prestwich, R. Slevin, N. West, C. Thomson, D. Patient involvement in the design of a phase III trial comparing IMPT and IMRT for oropharyngeal cancer. Clinical oncology, .